EVOFEM BIOSCIENCES, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $1.00K.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $16.00K, a 97.05% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $35.00K.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $543.00K, a 0.00% change year-over-year.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $52.00K.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.25M, a 77.91% decline from fiscal 2021.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $5.66M.
- EVOFEM BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $70.91M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-03-31 | $1.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $52.00K 10-K · filed 2026-03-11 | |
| 2024-06-30 | $16.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $35.00K 10-Q · filed 2025-11-13 | |
| 2023-06-30 | $543.00K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $1.25M 10-K · filed 2023-04-27 | |
| 2022-06-30 | $543.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $708.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $5.66M 10-K · filed 2023-04-27 | |
| 2016-12-31 | $5.00M 8-K/A · filed 2018-04-06 | |
| 2014-12-31 | $70.91M 10-K · filed 2017-03-23 |